The Global Health ESG rating stood at ‘Crisil ESG 64’ for fiscal year 2026, the company informed exchanges in a BSE filing dated October 5, 2026. Crisil ESG Ratings & Analytics Limited also assigned the company a Core ESG rating of ‘Crisil Core ESG 70’ for the same fiscal year.

Global Health Ltd said it had received a communication from the rating agency informing it of the assignments. The disclosure identifies two separate ratings:

  • ESG rating: Crisil ESG 64 for fiscal year 2026.
  • Core ESG rating: Crisil Core ESG 70 for fiscal year 2026.

The filing reports the assigned ratings without providing a rating rationale, component scores or a comparison with any previous assessment.

Company explains notification timeline

Global Health said the agency’s communication arrived at 8:10 p.m. on October 1, 2026, beyond the company’s working hours. It explained that October 2 was a national holiday on account of Gandhi Jayanti and was followed by the weekend.

According to the filing, the company became aware of the communication on October 5, 2026. It said it promptly initiated the process of informing the stock exchanges upon becoming aware of the rating communication.

The disclosure therefore distinguishes between the date on which the agency’s message was received and the date on which the company said it became aware of that message. The October 5 filing sets out this sequence alongside the two rating assignments.

Disclosure to BSE and NSE

The company submitted the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with the SEBI master circular dated January 30, 2026.

Addressed to both BSE Limited and the National Stock Exchange of India Limited, the filing lists Global Health’s BSE scrip code 543654 and NSE symbol MEDANTA. It carries reference GHL/2026-27/EXCH/62.

Rahul Ranjan, Company Secretary & Compliance Officer, signed the disclosure. The document lists the company’s registered office in Defence Colony, New Delhi.